Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer

doi:10.3748/wjg.v22.i3.1224

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11689)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

953

WORD

373

HTML

7078

Figures (1-2)

398

Tables (1-1)

261

Sum=9063

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

948

Download

1678

Sum=2626

Jan 21, 2016 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (25)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jan 21, 2016; 22(3): 1224-1235
Published online Jan 21, 2016. doi: 10.3748/wjg.v22.i3.1224

Full Size Figure Download Figure

Figure 1 Structural features of the group I and group II p21-activated kinases family members. PAK: p21-activated kinase; PBD: p21-binding domain; AID: Autoinhibitory domain.

Citation: Shao YG, Ning K, Li F. Group II p21-activated kinases as therapeutic targets in gastrointestinal cancer. World J Gastroenterol 2016; 22(3): 1224-1235
URL: https://www.wjgnet.com/1007-9327/full/v22/i3/1224.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i3.1224